With India set to roll out coronavirus vaccines, the Union Health Ministry has released a set of frequently -asked- questions related to the vaccines and the vaccination drive. India's drugs regulator on Sunday approved the Oxford COVID-19 vaccine Covishield, manufactured by the Serum Institute, and indigenously developed Covaxin of Bharat Biotech for restricted emergency use in the country. The Centre responded to queries about safety, side-effects, anti-bodies etc. Watch the video for more.
Also Read: DCGI approves Covaxin for children above 12 years, Covishield for above 18